The 2025-2030 World Outlook for Exosome Research Products - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Exosome Research Products

Subjects

Out of stock

Price data last checked 38 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 228 days. Could come back at any time — we're watching for you.

Out of stock 228 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 435 days · 435 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 435 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (435 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 435 days

Description

This study covers the world outlook for exosome research products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of exosome research products as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AMS Biotechnology EUROPE, Ltd., Bio-Techne, Lonza Group, Miltenyi Biotec, Nanosomix, Norgen Biotek, Novus Biologicals, NX Pharmagen, Qiagen, System Biosciences, and Thermo Fisher Scientific. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZ2JHSJR
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 27 April 2024

The 2025-2030 World Outlook for Exosome Research Products

Gone for 228 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 World Outlook for Exosome Research Products

The 2023 Report on Exosome Research Products: World Market Segmentation by City

The 2023 Report on DNA Testing: World Market Segmentation by City

The 2025-2030 World Outlook for DNA Testing

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in Japan

The 2023 Report on Point of Care Diagnostics: World Market Segmentation by City

Artificial Cells: Biotechnology, Nanomedicine, Regenerative Medicine, Blood Substitutes, Bioencapsulation, And Cell/Stem Cell Therapy,Vol 1 (Regenerative Medicine, Artificial Cells And Nanomedicine)

ARTIFICIAL CELLS: BIOTECHNOLOGY, NANOMEDICINE, REGENERATIVE MEDICINE, BLOOD SUBSTITUTES, BIOENCAPSULATION, AND CELL/STEM CELL THERAPY: 1 (Regenerative Medicine, Artificial Cells And Nanomedicine)

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs for US Zip Codes

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in India

The 2025-2030 World Outlook for Point of Care Diagnostics

The 2025-2030 World Outlook for Tissue Banking Equipment and Consumables

The 2023 Report on Cell Free Protein Expression: World Market Segmentation by City

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in China

The 2027-2032 World Outlook for Biotechnology Epigenetics

Humana Nuclear Reprogramming and Stem Cells Biology Book

The 2027-2032 World Outlook for Biotechnology Instrumentations

Academic Press - Engineering Strategies for Regenerative Medicine

Reshaping Healthcare with Cutting-Edge Biomedical Advancements

The 2027-2032 World Outlook for Biotechnology Reagents

The 2023 Report on Molecular Carrier Screening Tests: World Market Segmentation by City

The 2027-2032 World Outlook for Biotechnology Molecular Diagnostics

Gene Therapy Technologies, Applications and Regulations: From Laboratory to Clinic

Biomechatronic Design in Biotechnology: A Methodology for Development of Biotechnological Products